Evidence map›Paper›PMID 28151936›Full record

ArticlePloS one2017

Promoter Methylation Pattern Controls Corticotropin Releasing Hormone Gene Activity in Human Trophoblasts.

Xin Pan, Maria Bowman, Rodney J Scott, John Fitter, Roger Smith, Tamas Zakar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xin PanMothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Maria BowmanMothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Rodney J ScottPriority Research Centre for Reproductive Science, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia.
John FitterMothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Roger SmithMothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Tamas ZakarMothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.ORCID http://orcid.org/0000-0002-1690-1159
Hunter Medical Research Institute · AUJohn Hunter Hospital · AUHunter Genetics · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Placental CRH production increases with advancing pregnancy in women and its course predicts gestational length. We hypothesized that CRH gene expression in the placenta is epigenetically controlled setting gestational trajectories characteristic of normal and pathological pregnancies. Here we determined histone modification and DNA methylation levels and DNA methylation patterns at the CRH promoter in primary trophoblast cultures by chromatin immunoprecipitation combined with clonal bisulfite sequencing and identified the transcriptionally active epialleles that associate with particular histone modifications and transcription factors during syncytialisation and cAMP-stimulation. CRH gene expression increased during syncytial differentiation and cAMP stimulation, which was associated with increased activating and decreased repressive histone modification levels at the promoter. DNA methylation levels remained unchanged. The nine CpGs of the CRH proximal promoter were partially and allele-independently methylated displaying many (>100) epialleles. RNA-polymerase-II (Pol-II) bound only to three particular epialleles in cAMP-stimulated cells, while phospho-cAMP response element-binding protein (pCREB) bound to only one epiallele, which was different from those selected by Pol-II. Binding of TATA-binding protein increased during syncytial differentiation preferentially at epialleles compatible with Pol-II and pCREB binding. Histone-3 acetylation was detected only at epialleles targeted by Pol-II and pCREB, while gene activating histone-4 acetylation and histone-3-lysine-4 trimethylation occurred at CRH epialleles not associated with Pol-II or pCREB. The suppressive histone-3-lysine-27 trimethyl and-lysine-9 trimethyl modifications showed little or no epiallele preference. The epiallele selectivity of activating histone modifications and transcription factor binding demonstrates the epigenetic and functional diversity of the CRH gene in trophoblasts, which is controlled predominantly by the patterns, not the overall extent, of promoter methylation. We propose that conditions impacting on epiallele distribution influence the number of transcriptionally active CRH gene copies in the trophoblast cell population determining the gestational trajectory of placental CRH production in normal and pathological pregnancies.

Indexed as

AcetylationCells, CulturedCorticotropin-Releasing HormoneCpG IslandsCyclic AMP Response Element-Binding ProteinDNA MethylationFemaleHistonesHumansPlacentaPregnancyPromoter Regions, GeneticProtein BindingRNA Polymerase IITATA-Box Binding ProteinTranscription FactorsCorticotropin-Releasing HormoneCyclic AMP Response Element-Binding ProteinHistonesRNA Polymerase IITATA-Box Binding ProteinTranscription Factors

Identifiers

PMID28151936
PMCPMC5289476
OpenAlexW2585835695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.